Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Altmann

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2010
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMSC Tur, Z Khaleeli, O Ciccarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2011
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosisC Tur, S Penny, Z Khaleeli, et al.
Neurology|January 29, 2010
Spinal cord repair in MS: does mitochondrial metabolism play a role?O Ciccarelli, D R Altmann, M A McLean, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 7, 2014
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosisH Kearney, T Schneider, M C Yiannakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Acute axonal damage predicts clinical outcome in patients with multiple sclerosisE T Lim, F Sellebjerg, C V Jensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal studyW Rashid, G R Davies, D T Chard, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosisD R Altmann, T Button, K Schmierer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2009
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromesM Di Filippo, V M Anderson, D R Altmann, et al.
Neurology|March 9, 2005
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cordM Laura, W Leong, N M F Murray, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2006
Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosisM Bieniek, D R Altmann, G R Davies, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2010
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMSC Tur, Z Khaleeli, O Ciccarelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2011
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosisC Tur, S Penny, Z Khaleeli, et al.
Neurology|January 29, 2010
Spinal cord repair in MS: does mitochondrial metabolism play a role?O Ciccarelli, D R Altmann, M A McLean, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 7, 2014
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosisH Kearney, T Schneider, M C Yiannakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Acute axonal damage predicts clinical outcome in patients with multiple sclerosisE T Lim, F Sellebjerg, C V Jensen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal studyW Rashid, G R Davies, D T Chard, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosisD R Altmann, T Button, K Schmierer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2009
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromesM Di Filippo, V M Anderson, D R Altmann, et al.
Neurology|March 9, 2005
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cordM Laura, W Leong, N M F Murray, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2006
Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosisM Bieniek, D R Altmann, G R Davies, et al.
Pageof 5